Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
1/28/15 Serendex Molgramostim for Pulmonary Alveolar Proteinosis (PAP) Subscribers Only Subscribers Only Subscribers Only
1/28/15 Sorrento Therapeutics (SRNE) Cynviloq for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
1/28/15 Advaxis (ADXS) ADXS-HPV for Cervical Cancer Subscribers Only Subscribers Only Subscribers Only
1/28/15 MediciNova (MNOV) MN-001 for Non-alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only
1/28/15 Alexion (ALXN) Soliris for Hemolytic Uremic Syndrome (HUS) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
01/29/15 Subscribers Only Subscribers Only Progress Update - Product Launch
01/29/15 Subscribers Only Subscribers Only Partnership - Acquisition Completion
01/29/15 Subscribers Only Subscribers Only Partnership - Acquisition Completion
01/29/15 Subscribers Only Subscribers Only Company - Earnings Announcement
01/29/15 Subscribers Only Subscribers Only Company - Earnings Announcement